RYH Invesco S&P 500 Equal Weight Health Care ETF
报价截至 Jun 12, 2025 13:42 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| 前收盘价 | 287.42 | 当日价格区间 | 285.95 – 289.66 |
| 52周区间 | 248.94 – 304.15 | 成交量 | 8.41K |
| 平均成交量 | 8.12K | AUM | $960.7M (Aug 27, 2026) |
| 费用率 | 0.40% | 收益率（TTM） | 0.08% |
| NAV | 29.14 | 溢价/折价 | +885.11% 参考性 |
| 成立日期 | Nov 01, 2006 | 持仓明细 | 66 |
| 发行方 | Invesco | 交易所 | AMEX |
| 类别 | Healthcare | 跟踪指数 | S&P 500 |
| CUSIP | 46137V332 | ISIN | US46137V3327 |
| 管理 | 来源数据中未说明 | ||
关于本ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of all of the components of the S&P 500® Health Care Index, an index that contains the common stocks of all companies included in the S&P 500® Index that are classified as members of the health care sector, as defined according to the Global Industry Classification Standard (GICS).
来自基金数据提供商的描述 · 截至以下日期的概况： Aug 27, 2026.
价格走势图
每日收盘价（价格回报，非总回报）。对比折线图以区间起始点为基准，标准化为百分比变动。 来源: Financial Modeling Prep.
业绩表现
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | 成立* | |
|---|---|---|---|---|---|---|---|---|---|
| 价格回报 | — | — | — | — | — | -52.53% | -33.31% | -15.70% | -2.85% |
| 总回报 | — | — | — | — | — | -52.46% | -33.24% | -15.51% | -2.67% |
* 已年化。总回报率采用股息调整后价格序列计算（分红再投入）；价格回报率采用未经调整的收盘价计算。 业绩截至 Jul 10, 2025. 过往业绩不代表未来表现。
费率
| 净费率 | 0.40% | 每10,000美元投资的年化费用 | $40.00 |
仅供示意的费用测算：费用率 × $10,000。不含交易成本、买卖价差、税费及投资价值变动。总费用率与净费用率的详情及任何费用减免安排，请参阅招募说明书。
持仓明细
持仓数据截至 Aug 26, 2026 — 数据提供商报告的投资组合日期；持仓数据非实时仓位。 64 数据库总行数.
| # | 持仓 | 代码 | 权重 | 股票 | 市值 |
|---|---|---|---|---|---|
| 1 | Moderna Inc | MRNA | 4.89% | 258.49K | $41.1M |
| 2 | Charles River Laboratories International Inc | CRL | 2.26% | 63.80K | $19.0M |
| 3 | Veeva Systems Inc | VEEV | 2.14% | 72.58K | $17.9M |
| 4 | IQVIA Holdings Inc | IQV | 2.02% | 65.30K | $16.9M |
| 5 | Regeneron Pharmaceuticals Inc | REGN | 1.96% | 19.76K | $16.5M |
| 6 | Bio-Techne Corp | TECH | 1.95% | 226.39K | $16.4M |
| 7 | Merck & Co Inc | MRK | 1.86% | 99.74K | $15.6M |
| 8 | Amgen Inc | AMGN | 1.86% | 35.19K | $15.6M |
| 9 | Thermo Fisher Scientific Inc | TMO | 1.85% | 24.66K | $15.5M |
| 10 | Abbott Laboratories | ABT | 1.85% | 133.36K | $15.5M |
| 11 | Baxter International Inc | BAX | 1.83% | 585.00K | $15.4M |
| 12 | Becton Dickinson & Co | BDXA | 1.82% | 80.43K | $15.3M |
| 13 | Vertex Pharmaceuticals Inc | VRTX | 1.80% | 27.28K | $15.1M |
| 14 | Labcorp Holdings Inc | LH | 1.78% | 44.22K | $14.9M |
| 15 | Mettler-Toledo International Inc | MTD | 1.76% | 10.53K | $14.8M |
| 16 | Revvity Inc | PKI | 1.75% | 117.28K | $14.6M |
| 17 | Incyte Corp | INCY | 1.74% | 112.73K | $14.6M |
| 18 | Gilead Sciences Inc | GILD | 1.73% | 97.75K | $14.5M |
| 19 | ResMed Inc | RMD | 1.73% | 61.41K | $14.5M |
| 20 | Bristol-Myers Squibb Co | BMY | 1.73% | 213.73K | $14.5M |
| 21 | Universal Health Services Inc | UHS | 1.72% | 82.02K | $14.4M |
| 22 | Quest Diagnostics Inc | DGX | 1.70% | 58.34K | $14.3M |
| 23 | Dexcom Inc | DXCM | 1.69% | 158.91K | $14.2M |
| 24 | AbbVie Inc | ABBV | 1.67% | 52.83K | $14.0M |
| 25 | Danaher Corp | DHR | 1.67% | 64.75K | $14.0M |
点击股票代码，查看所有持有该证券的ETF。
行业敞口
地区敞口
国家/地区权重以数据提供商报告为准。发达/新兴/前沿市场的分类标签遵循方法论页面中的分类标准。 货币对冲: 基金名称中未显示对冲信息.
分红记录
| 收益率（TTM） | 0.08% | 已派发（过去12个月） | $0.2318 |
| 频率 | Quarterly | SEC收益率 | 我们的数据来源未提供此信息——请参阅发行方页面 |
| 最近除息日 | Jun 22, 2026 | 最近派息 | $0.0627 |
| 1年增长率 | +40.24% | 3年/5年增长率（年化） | +7.93% / +13.17% |
| 除息日 | 股权登记日 | 派息日 | 金额 |
|---|---|---|---|
| Jun 22, 2026 | — | — | $0.0627 |
| Mar 23, 2026 | — | — | $0.0561 |
| Dec 22, 2025 | — | — | $0.0530 |
| Sep 22, 2025 | — | — | $0.0599 |
| Jun 23, 2025 | — | — | $0.0555 |
| Mar 24, 2025 | — | — | $0.0551 |
| Sep 23, 2024 | — | — | $0.0547 |
| Jun 24, 2024 | — | — | $0.0508 |
| Mar 18, 2024 | — | — | $0.0459 |
| Dec 18, 2023 | — | — | $0.0499 |
| Sep 18, 2023 | — | — | $0.0479 |
| Jun 20, 2023 | — | — | $0.0511 |
追踪分派收益率 = 过去 12 个月现金分派 ÷ 当前价格。此数据并非 SEC 30 日收益率，且分派金额不保证持续。 差异解析 →
风险统计
流动性
| 今日成交量 | 8.41K | 平均成交量 | 8.12K |
| AUM | $960.7M | 溢价/折价 | +885.11% |
| 买卖价差 | 我们的数据来源未提供此信息。请查看您券商的报价页面；买卖价差在开盘和收盘时最大。 | ||
溢价/折价将延迟市场价格与最近披露的净值（NAV）进行比较——此数据为参考性数据，并非官方收盘溢价/折价。 ETF流动性机制详解 →
基金官方资源
外部链接将在新标签页中打开发行商官网或SEC EDGAR。招募说明书及官方文件始终是权威依据——投资前请务必仔细阅读。
最新资讯： RYH
过去7天内暂无文章直接提及该基金——显示ETF行业综合报道。
使用指引：AUM为基金规模；费用率为内嵌于收益中的年度成本；NAV为基金每份资产净值，市场价格可能略高于NAV（溢价）或略低于NAV（折价）；总回报假设分配收益已再投资。每项数据集均显示各自的截止日期，因为持仓、资产和报价的更新频率不同。